Lyme disease and tinnitus: what the evidence actually shows

Lyme disease is primarily known for the bull’s-eye rash, joint pain, fatigue, and cardiac and neurological complications that follow untreated infection with Borrelia burgdorferi, the bacterium transmitted by Ixodes ticks. What receives less attention is the condition’s potential to produce audiovestibular symptoms, including tinnitus, sensorineural hearing loss, and dizziness.

The evidence linking Lyme disease to tinnitus is real but modest. This matters because patients with both conditions sometimes ask whether the two are connected, and the honest answer is: sometimes yes, more often unclear. The literature is dominated by case reports and small series rather than large controlled studies, and the clinical picture is complicated by the fact that Lyme disease is often overdiagnosed and that tinnitus is independently common in the population.

How Lyme disease can affect the auditory system

Borrelia burgdorferi can cause neurological complications, classified collectively as Lyme neuroborreliosis, when the infection spreads to the nervous system. This typically happens weeks to months after the initial tick bite if the infection goes untreated.

Cranial nerve involvement is one recognized feature of Lyme neuroborreliosis. The seventh cranial nerve (facial nerve) is the most commonly affected cranial nerve in Lyme disease, producing peripheral facial palsy. The eighth cranial nerve, carrying auditory and vestibular signals from the inner ear to the brainstem, can also be involved. When it is, the result may be sensorineural hearing loss, vertigo, tinnitus, or some combination.

Direct cochlear involvement is less well established. The NIH/NIAID notes that the mechanism by which Lyme affects auditory function is not fully characterized. Inflammation of the eighth nerve itself is the leading hypothesis for most cases. Vasculitis affecting cochlear blood supply and direct cochlear infiltration by the organism are other proposed mechanisms, but the evidence for each in clinical Lyme disease is limited.

What the clinical literature shows

Case reports of Lyme-associated sudden sensorineural hearing loss, bilateral sequential SNHL, and tinnitus with accompanying positive Lyme serology have been published over several decades. These cases demonstrate that the association exists.

More systematic data come from cohort studies of Lyme neuroborreliosis patients, which document audiovestibular symptoms in a minority of those with confirmed neurological Lyme disease. A systematic review published in ENT specialty journals found that audiovestibular symptoms occurred in a subset of patients with Lyme neuroborreliosis and that most improved with antibiotic treatment, though residual symptoms were reported in a proportion.

The critical limitation throughout this literature is that Lyme serology is positive in a meaningful percentage of the general population in endemic areas (false positives being a recognized issue with single-tier ELISA testing), and tinnitus is independently common. Attributing tinnitus to Lyme disease in a patient with positive serology and no other signs of neuroborreliosis requires careful clinical judgment, not a simple blood test result.

The diagnostic framework

The CDC recommends a two-tier testing approach: an initial ELISA, and if positive or equivocal, a confirmatory Western blot. Positive two-tier serology in the right clinical context supports the diagnosis of Lyme disease, but it does not by itself prove that tinnitus or hearing loss is Lyme-related.

Mayo Clinic describes the typical workup for suspected Lyme neuroborreliosis as including serologic testing, lumbar puncture (to look for signs of CNS inflammation and Borrelia antibodies in the cerebrospinal fluid), MRI, and neurological assessment. An ENT evaluation and audiometry assess the degree and pattern of any auditory impairment.

Patients presenting with audiovestibular symptoms and potential Lyme exposure should have the complete audiometric picture evaluated (type and degree of loss, word recognition scores, ABR if indicated) alongside the infectious disease evaluation. This allows each specialist to contribute their part of the picture.

Treatment

Standard antibiotic regimens for Lyme neuroborreliosis are the treatment framework when active nervous system involvement is confirmed. For early Lyme disease without neurological features, oral doxycycline is the standard. For neuroborreliosis, intravenous ceftriaxone for two to four weeks is commonly used, though oral doxycycline has evidence in some neuroborreliosis presentations.

The NIH/NIAID notes that most patients with Lyme disease, including those with neurological involvement, recover fully with appropriate treatment. When audiovestibular symptoms are directly attributable to active infection, resolution or significant improvement with antibiotic therapy is the expected outcome.

However, some patients develop what is labeled post-treatment Lyme disease syndrome (PTLDS), characterized by persistent fatigue, pain, and cognitive symptoms despite documented treatment. Persistent tinnitus has been reported in this context. The mechanism of PTLDS is debated, and there is no established evidence that extended antibiotic courses beyond the standard regimen improve outcomes. This remains a contested area of Lyme disease medicine.

The overlap problem

A practical challenge in clinical care is the patient who has been diagnosed with Lyme disease at some point and later develops tinnitus, months or years apart. Without careful attention to timing, tick exposure history, and the full serologic and neurological picture, it is easy either to over-attribute the tinnitus to Lyme disease or to dismiss a genuine connection.

The NHS UK recommends that any patient with unexplained sensorineural hearing loss receive full audiological evaluation, regardless of what other diagnoses may be present. This applies to patients with Lyme disease histories as well: the hearing loss should be characterized independently and not assumed to have a known cause without evaluation.

When tinnitus and hearing change develop during an active Lyme disease episode, or shortly after diagnosis of neuroborreliosis, the temporal relationship makes the connection more plausible and warrants prompt audiological evaluation alongside antibiotic treatment.

If symptoms persist or change, see an audiologist or physician.